RegASK Founder & CEO Caroline Schleifer joins the Amplifiz Podcast with host Guillaume Villard to unpack the evolving landscape of regulatory affairs and compliance in Pharma and MedTech and why strategic intelligence is becoming central to global market access.
In this episode of the Amplifiz Podcast, Caroline Schleifer discusses the current state and future outlook of regulatory affairs and compliance within highly regulated industries like Pharma and MedTech. Drawing on insights from RegASK’s 2026 State of Regulatory Affairs & Compliance Report, she explains how regulatory and compliance teams are evolving from traditional compliance functions into strategic partners that enable faster, safer global market access.
Caroline highlights how AI-driven regulatory intelligence helps teams monitor emerging requirements, assess impact with greater accuracy, and streamline workflows that historically depended on manual effort. She also shares how RegASK’s technology equips global teams with always-on regulatory monitoring, automated impact assessments, and intelligent workflow orchestration — empowering organizations to reduce compliance risk, make faster decisions, and focus resources on strategic priorities.
Gründer und CEO, RegASK
Caroline Schleifer is the Founder and CEO of RegASK, a global platform for AI-driven regulatory intelligence that helps organizations identify regulatory risks, monitor global changes, and orchestrate compliance workflows with confidence.
With deep experience spanning regulatory affairs, compliance strategy, and technology across industries and regions, Caroline brings a strategic perspective to navigating complexity in highly regulated environments. Under her leadership, RegASK has positioned itself at the forefront of AI-enabled regulatory operations, empowering teams to transform compliance from a cost center into a strategic advantage.
Discover how RegASK helps organizations automate regulatory intelligence, identify risks early, and execute compliance strategies efficiently across markets.
